(Q38419238)

2 September 2017

1 reference

title

The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). (English)

1 reference

2 September 2017

cardiovascular disease

1 reference

Hawa N Siti

1

1 reference

PubMed ID

25869516

2 September 2017

Y Kamisah

series ordinal

2

1 reference

PubMed ID

25869516

2 September 2017

J Kamsiah

series ordinal

3

1 reference

2 September 2017

11 April 2015

1 reference

2 September 2017

Vascular Pharmacology

1 reference

2 September 2017

71

1 reference

2 September 2017

40-56

1 reference

Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II.

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Tumor necrosis factor-alpha: a possible priming agent for the polymorphonuclear leukocyte-reduced nicotinamide-adenine dinucleotide phosphate oxidase in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Low-grade inflammation and ambulatory blood pressure response to antihypertensive treatment: the ALPHABET study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Systemic inflammation and brachial artery endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Asymmetric dimethylarginine (ADMA) and soluble vascular cell adhesion molecule 1(sVCAM-1) as circulating markers for endothelial dysfunction in patients with pheochromocytoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Endothelial function and dysfunction: testing and clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Oxidative stress, nitric oxide synthase, and superoxide dismutase: a matter of imbalance underlies endothelial dysfunction in the human coronary circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Oxidative stress: oxidants and antioxidants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

NADPH oxidase and endothelial cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin II-induced inflammation and hypertension: regulation of oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Total antioxidant capacity: appraisal of a concept

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Plasma and dietary antioxidant status as cardiovascular disease risk factors: a review of human studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Redox signaling in pathophysiology of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Molecular hydrogen: new antioxidant and anti-inflammatory therapy for rheumatoid arthritis and related diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

The role of repeatedly heated soybean oil in the development of hypertension in rats: association with vascular inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Vascular inflammation and endothelial dysfunction in experimental hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

The Renin-Angiotensin-aldosterone system in vascular inflammation and remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

C-reactive protein induces release of both endothelial microparticles and circulating endothelial cells in vitro and in vivo: further evidence of endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Intake of repeatedly heated palm oil causes elevation in blood pressure with impaired vasorelaxation in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Endothelial dysfunction in chronic inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Dual neural endopeptidase/endothelin-converting [corrected] enzyme inhibition improves endothelial function in mesenteric resistance arteries of young spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Erythropoietin-induced hypertension and vascular injury in mice overexpressing human endothelin-1: exercise attenuated hypertension, oxidative stress, inflammation and immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Endothelin-1 (ET-1) increases the expression of remodeling genes in vascular smooth muscle through linked calcium and cAMP pathways: role of a phospholipase A(2)(cPLA(2))/cyclooxygenase-2 (COX-2)/prostacyclin receptor-dependent autocrine loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Endothelin-1 induces a glycolytic switch in pulmonary arterial endothelial cells via the mitochondrial translocation of endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Chlorine gas exposure causes systemic endothelial dysfunction by inhibiting endothelial nitric oxide synthase-dependent signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

DIESEL particulate exposed macrophages alter endothelial cell expression of eNOS, iNOS, MCP1, and glutathione synthesis genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Inducible nitric oxide synthase as a possible target in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

META060 attenuates TNF-α-activated inflammation, endothelial-monocyte interactions, and matrix metalloproteinase-9 expression, and inhibits NF-κB and AP-1 in THP-1 monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Inflammatory cytokines in vascular dysfunction and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Essential role for STIM1/Orai1-mediated calcium influx in PDGF-induced smooth muscle migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

PI3Kγ inhibition reduces blood pressure by a vasorelaxant Akt/L-type calcium channel mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Lercanidipine and labedipinedilol--A attenuate lipopolysaccharide/interferon-γ-induced inflammation in rat vascular smooth muscle cells through inhibition of HMGB1 release and MMP-2, 9 activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Calcium-activated potassium channels and the regulation of vascular tone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

TRPM2-mediated Ca2+influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Circulating mitochondrial DAMPs cause inflammatory responses to injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Upregulation of heme oxygenase-1 potentiates EDH-type relaxations in the mesenteric artery of the spontaneously hypertensive rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Apelin elevates blood pressure in ICR mice with L‑NAME‑induced endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Tumor necrosis factor-α produced in the kidney contributes to angiotensin II-dependent hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Interleukin-10 reduces inflammation, endothelial dysfunction, and blood pressure in hypertensive pregnant rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Anti-oxidant and anti-inflammatory mechanisms of amlodipine action to improve endothelial cell dysfunction induced by irreversibly glycated LDL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Tomato extract and the carotenoids lycopene and lutein improve endothelial function and attenuate inflammatory NF-κB signaling in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Impaired vasodilation in the pathogenesis of hypertension: focus on nitric oxide, endothelial-derived hyperpolarizing factors, and prostaglandins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Role of Renin-Angiotensin system and oxidative stress on vascular inflammation in insulin resistence model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Stiffness Increases Mononuclear Cell Transendothelial Migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Low-grade inflammation, but not endothelial dysfunction, is associated with greater carotid stiffness in the elderly: the Hoorn Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Elevated levels of MMP-9 in untreated patients with stage I essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

LOX-1, OxLDL, and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

The reciprocal relationship between adiponectin and LOX-1 in the regulation of endothelial dysfunction in ApoE knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

LOX-1 and ROS, inseparable factors in the process of endothelial damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

ox-LDL downregulates eNOS activity via LOX-1-mediated endoplasmic reticulum stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Utility of Lp-PLA2 in lipid-lowering therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Direct Inhibition of Cyclooxygenase-1 and -2 by the Kinase Inhibitors SB 203580 and PD 98059

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Binding to PLA2 may contribute to the anti-inflammatory activity of catechol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Cyclooxygenase-1 and prostacyclin production by endothelial cells in the presence of mild oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Platelet activation and atherothrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Role of interferon alpha in endothelial dysfunction: insights into endothelial nitric oxide synthase-related mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Molecular mechanisms of hypertension: role of Nox family NADPH oxidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Is oxidative stress a therapeutic target in cardiovascular disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Irbesartan, an angiotensin receptor blocker, exhibits metabolic, anti-inflammatory and antioxidative effects in patients with high-risk hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Selenium and coronary heart disease: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Vitamin C prevents DNA damage induced by renovascular hypertension in multiple organs of Wistar rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Acute superoxide scavenging restores depressed baroreflex sensitivity in renovascular hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Effect of acute administration of vitamin C on muscle sympathetic activity, cardiac sympathovagal balance, and baroreflex sensitivity in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Oral vitamin C enhances the adrenergic vasoconstrictor response to local cooling in human skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Does vitamin C or its combination with vitamin E improve radial artery endothelium-dependent vasodilatation in patients awaiting coronary artery bypass surgery?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Role of vitamin C in the function of the vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Synthetic or food-derived vitamin C - are they equally bioavailable?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Differing Relations to Early Atherosclerosis between Vitamin C from Supplements vs. Food in the Los Angeles Atherosclerosis Study: A Prospective Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Polyphenol-containing azuki bean (Vigna angularis) seed coats attenuate vascular oxidative stress and inflammation in spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Suppressive effects of cacao polyphenols on the development of atherosclerosis in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Identification of microRNAs involved in the modulation of pro-angiogenic factors in atherosclerosis by a polyphenol-rich extract from propolis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Beneficial effects of polyphenol-rich olive oil in patients with early atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Red wine polyphenols do not lower peripheral or central blood pressure in high normal blood pressure and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Effect of polyphenol-rich grape seed extract on ambulatory blood pressure in subjects with pre- and stage I hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Euterpe oleracea Mart.-derived polyphenols prevent endothelial dysfunction and vascular structural changes in renovascular hypertensive rats: role of oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Effect of the flavonoid fraction of Lithocarpus polystachyus Rehd. on spontaneously hypertensive and normotensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Prevention of atherosclerosis progression by 9-cis-β-carotene rich alga Dunaliella in apoE-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Long-term vitamin E supplementation reduces atherosclerosis and mortality in Ldlr-/- mice, but not when fed Western style diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Effects of vitamin E on peroxisome proliferator-activated receptor γ and nuclear factor-erythroid 2-related factor 2 in hypercholesterolemia-induced atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Dose dependent elevation of plasma tocotrienol levels and its effect on arterial compliance, plasma total antioxidant status, and lipid profile in healthy humans supplemented with tocotrienol rich vitamin E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Measurement of total antioxidant capacity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Antihypertensive and antioxidant action of amlodipine and vitamin C in patients of essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Selenium supplementation does not improve vascular responsiveness in healthy North American men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Quercetin reduces blood pressure in hypertensive subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Dietary Intakes of Flavonols and Flavones and Coronary Heart Disease in US Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Both alpha- and beta-carotene, but not tocopherols and vitamin C, are inversely related to 15-year cardiovascular mortality in Dutch elderly men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Total antioxidant capacity of the diet is associated with lower risk of ischemic stroke in a large Italian cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

Total Antioxidant Capacity of Diet and Risk of Stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2015.03.005

10.1016/J.VPH.2015.03.005

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference

PubMed ID

25869516